{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:32:13Z","timestamp":1792654333917,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.transci.2017.07.023","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T14:37:23Z","timestamp":1502203043000},"page":"595-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Blood derived eye drops for the treatment of cornea and ocular surface diseases"],"prefix":"10.1016","volume":"56","author":[{"given":"Giuseppe","family":"Giannaccare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Versura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Buzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Primavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio C.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2017.07.023_bib0005","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","article-title":"Clinical experience with a mobile ocular perfusion pump","volume":"93","author":"Ralph","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2017.07.023_bib0015","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0161-6420(99)90412-8","article-title":"Treatment of persistent corneal epithelial defect by autologous serum application","volume":"106","author":"Tsubota","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.transci.2017.07.023_bib0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sjogren\u2019s syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0025","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1167\/iovs.11-7340","article-title":"In vitro effects of three blood derivatives on human corneal epithelial cells","volume":"53","author":"Freire","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.transci.2017.07.023_bib0030","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bjo.85.10.1188","article-title":"Autologous serum eye drops for dry eyes and epithelial defects: clinical and in vitro toxicity studies","volume":"85","author":"Poon","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0035","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/01.ico.0000208817.40237.8c","article-title":"Effects of autologous serum eye drops on corneal wound healing after superficial keratectomy in rabbits","volume":"25","author":"Akyol-Salman","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0040","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1167\/iovs.07-0770","article-title":"The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture","volume":"48","author":"Gipson","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.transci.2017.07.023_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1350-9462(99)00007-5","article-title":"Growth factors: importance in wound healing and maintenance of transparency of the cornea","volume":"19","author":"Imanishi","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.transci.2017.07.023_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004170050034","article-title":"The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes","volume":"236","author":"Pancholi","year":"1998","journal-title":"Graefe Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0055","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.3306916","article-title":"The nerve growth factor 35 years later","volume":"237","author":"Levi-Montalcini","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.transci.2017.07.023_bib0060","first-page":"1063","article-title":"Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas","volume":"41","author":"Lambiase","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.transci.2017.07.023_bib0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/978-1-4615-0717-8_75","article-title":"Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface","volume":"506","author":"Bonini","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.transci.2017.07.023_bib0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00003226-198706020-00005","article-title":"Application of homologous fibronectin to persistent human corneal epithelial defects","volume":"6","author":"Spigelman","year":"1988","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0161-6420(83)34512-7","article-title":"Effects of vitamin A deficiency on the ocular surface","volume":"90","author":"Sommer","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.transci.2017.07.023_bib0080","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders","volume":"88","author":"Geerling","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0085","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00417-004-1106-5","article-title":"An optimised protocol for the production of autologous serum eyedrops","volume":"243","author":"Liu","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/vox.12502","article-title":"Serum eye drops: a survey of international production methods","volume":"112","author":"Marks","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2017.07.023_bib0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2014.09.012","article-title":"The corneal fibrosis response to epithelial-stromal injury","volume":"142","author":"Torricelli","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.transci.2017.07.023_bib0100","first-page":"CD009327","article-title":"Autologous serum eye drops for dry eye","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transci.2017.07.023_bib0105","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/ICO.0b013e3181a2a7f6","article-title":"Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects","volume":"28","author":"Jeng","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0110","doi-asserted-by":"crossref","first-page":"521315","DOI":"10.1155\/2013\/521315","article-title":"Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery","volume":"2013","author":"Lekhanont","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.transci.2017.07.023_bib0115","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00003226-200111000-00005","article-title":"Controlled study of the use of autologous serum in dry eye patients","volume":"20","author":"Tananuvat","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","article-title":"Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease","volume":"88","author":"Noble","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/02713683.2012.674609","article-title":"Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome","volume":"37","author":"Urzua","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.transci.2017.07.023_bib0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","article-title":"The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study","volume":"252","author":"Celebi","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2010.03.024","article-title":"The effect of topical autologous serum on graft re-epithelialization after penetrating keratoplasty","volume":"150","author":"Chen","year":"2010","journal-title":"Am J Ophthalmo"},{"key":"10.1016\/j.transci.2017.07.023_bib0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3928\/1081-597X-20060101-13","article-title":"Autologous serum eye drops for dry eye after LASIK","volume":"22","author":"Noda-Tsuruya","year":"2006","journal-title":"J Refract Surg"},{"key":"10.1016\/j.transci.2017.07.023_bib0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1442-9071.2010.02304.x","article-title":"Long-term follow up of autologous serum treatment for recurrent corneal erosions","volume":"38","author":"Ziakas","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0155","doi-asserted-by":"crossref","first-page":"v262","DOI":"10.1016\/j.ophtha.2007.03.087","article-title":"Autologous serum eye-drops in the treatment of aniridic keratopathy","volume":"115","author":"Lopez-Garcia","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.transci.2017.07.023_bib0160","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","article-title":"Autologous serum application in the treatment of neurotrophic keratopathy","volume":"111","author":"Matsumoto","year":"2004","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.transci.2017.07.023_bib0165","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/aos.12801","article-title":"Improving the anti-inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction","volume":"93","author":"Stenwall","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"10.1016\/j.transci.2017.07.023_bib0170","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00417-015-3056-5","article-title":"Comparison of epitheliotrophic factors in autologous serum eyedrops from sera of chronic renal failure patients vs. normal controls","volume":"253","author":"Kang","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2008-1027199","article-title":"Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis","volume":"225","author":"Harloff","year":"2008","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.transci.2017.07.023_bib0180","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/aos.12386","article-title":"Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy","volume":"92","author":"Harritsh\u00f8j","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0185","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bjophthalmol-2012-301668","article-title":"Allogeneic serum eye drops: time these became the norm?","volume":"96","author":"Badami","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0190","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.eye.6703079","article-title":"Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect","volume":"23","author":"Chiang","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.transci.2017.07.023_bib0195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/jop.2012.0002","article-title":"Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease","volume":"28","author":"Na","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.transci.2017.07.023_bib0200","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","article-title":"Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"26","author":"Chiang","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1705566","article-title":"Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease","volume":"39","author":"Yoon","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2017.07.023_bib0210","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4068\/cmj.2014.50.3.82","article-title":"Use of umbilical cord serum in ophthalmology","volume":"50","author":"Yoon","year":"2014","journal-title":"Chonnam Med J"},{"key":"10.1016\/j.transci.2017.07.023_bib0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/ICO.0b013e3182580762","article-title":"Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye","volume":"32","author":"Versura","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0220","first-page":"145","article-title":"Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops","volume":"14","author":"Versura","year":"2016","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2017.07.023_bib0225","first-page":"44","article-title":"Cord blood serum-based eye drops: the impact of donor haematological and obstetric factors on the variability of epidermal growth factor levels","volume":"12","author":"Versura","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2017.07.023_bib0230","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ico.0000183484.85636.b6","article-title":"Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome","volume":"25","author":"Yoon","year":"2006","journal-title":"Cornea"},{"issue":"November (11)","key":"10.1016\/j.transci.2017.07.023_bib0235","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bjo.87.11.1312","article-title":"Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects","volume":"87","author":"Vajpayee","year":"2003","journal-title":"BR J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0240","first-page":"807","article-title":"Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects","volume":"7","author":"Erdem","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0245","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3341\/kjo.2005.19.3.174","article-title":"Therapeutic effect of umbilical cord serum eye drops for persistent corneal epithelial defect","volume":"19","author":"Yoon","year":"2005","journal-title":"Korean J Ophthalmol"},{"issue":"144","key":"10.1016\/j.transci.2017.07.023_bib0250","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2007.03.016","article-title":"Comparison of autologous serum and umbilical cord serum eyedrops for dry eye syndrome","volume":"642","author":"Yoon","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0255","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1167\/iovs.09-4170","article-title":"Evaluation of umbilical cord serum therapy in acute ocular chemical burns","volume":"52","author":"Sharma","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.transci.2017.07.023_bib0260","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/ICO.0b013e31820d850f","article-title":"Application of umbilical cord serum eye drops for recurrent corneal erosions","volume":"30","author":"Yoon","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0265","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.ophtha.2006.12.014","article-title":"Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis","volume":"114","author":"Yoon","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.transci.2017.07.023_bib0270","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1755-3768.2012.02538.x","article-title":"Application of umbilical cord serum eyedrops after laser epithelial keratomileusis","volume":"91","author":"Yoon","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0275","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1054\/ijom.2003.0466","article-title":"Effect of platelet-rich plasma on bone regeneration in autogenous bone graft","volume":"33","author":"Choi","year":"2004","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.transci.2017.07.023_bib0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/ICU.0000000000000169","article-title":"Eye platet-rich plasma in the treatment of ocular surface disorders","volume":"26","author":"Alio","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0285","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/jop.2016.0166","article-title":"The effect of immunologically safe plasma rich in growth factor eye drops in patients with Sj\u00f6gren syndrome","volume":"33","author":"Sanchez-Avila","year":"2017","journal-title":"Ocul Pharmacol Ther"},{"key":"10.1016\/j.transci.2017.07.023_bib0290","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bmt.2012.64","article-title":"Autologous platelet lysate for treatment of refractory ocular GVHD","volume":"47","author":"Pezzotta","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2017.07.023_bib0295","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.2042-7158.2010.01208.x","article-title":"Platelet lysate formulations based on mucoadhesive polymers for the treatment of corneal lesions","volume":"63","author":"Sandri","year":"2011","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.transci.2017.07.023_bib0300","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000100933","article-title":"Symptomatic dry eye treatment with autologous platelet-rich plasma","volume":"39","author":"Alio","year":"2007","journal-title":"Ophthal Res"},{"key":"10.1016\/j.transci.2017.07.023_bib0305","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/ICO.0b013e3181a81820","article-title":"Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects","volume":"29","author":"Lopez-Plandolit","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0310","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10384-012-0175-y","article-title":"Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis","volume":"56","author":"Kim","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0315","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/112067210901900603","article-title":"Subconjunctival application of regenerative factor-rich plasma for the treatment of ocular alkali burns","volume":"19","author":"Marquez De Aracena Del Cid","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0320","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ophtha.2006.10.044","article-title":"Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers","volume":"14","author":"Alio","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.transci.2017.07.023_bib0325","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/ICO.0b013e3182114661","article-title":"Topical autologous platelet-rich plasma eyedrops for acute corneal chemical injury","volume":"31","author":"Panda","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0330","doi-asserted-by":"crossref","first-page":"8406832","DOI":"10.1155\/2016\/8406832","article-title":"The effect of autologous platelet lysate eye drops: an in vivo confocal microscopy study","volume":"2016","author":"Fea","year":"2016","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.transci.2017.07.023_bib0335","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3928\/1081-597X-20070601-13","article-title":"Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma","volume":"23","author":"Alio","year":"2007","journal-title":"J Refract Surg"},{"key":"10.1016\/j.transci.2017.07.023_bib0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3341\/kjo.2016.30.2.101","article-title":"Autologous platelet-rich plasma eye drops in the treatment of recurrent corneal erosions","volume":"30","author":"Lee","year":"2016","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0345","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/ICO.0b013e31825a6d9a","article-title":"Bovine pericardium membrane (Tutopatch) combined with solid platelet-rich plasma for the management of perforated corneal ulcers","volume":"32","author":"Alio","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.transci.2017.07.023_bib0350","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamaophthalmol.2013.2474","article-title":"Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study","volume":"131","author":"Alio","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.transci.2017.07.023_bib0355","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/IMCRJ.S89968","article-title":"Synergistic effect of regenerating agent plus cord blood serum eye drops for the treatment of resistant neurotrophic keratitis: a case report and a hypothesis for pathophysiologic mechanism","volume":"8","author":"Giannaccare","year":"2015","journal-title":"Int Med Case Rep J"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T04:01:45Z","timestamp":1569988905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050217301519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1473050217301519"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2017.07.023","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood derived eye drops for the treatment of cornea and ocular surface diseases","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2017.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}